Description
PT-141 — Melanocortin-4 Receptor Agonist
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It primarily acts on MC4R in the central nervous system and has been the subject of clinical investigation and preclinical research examining melanocortin pathway signaling and central arousal mechanisms.
Specifications:
- Purity: ≥99% (HPLC verified)
- Quantity: 10mg lyophilized powder
- Form: Sterile, lyophilized
- Storage: Store at -20°C, protect from light
For laboratory research purposes only. Not for human consumption.

Reviews
There are no reviews yet.